Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients. (Record no. 9602296)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01575 a2200457 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513144514.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199807s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0284-186X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1080/028418698429757 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Carles, J |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19980702 |
245 00 - TITLE STATEMENT | |
Title | Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Acta oncologica (Stockholm, Sweden) |
Date of publication, distribution, etc. | 1998 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 187-91 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adenocarcinoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Administration Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Estramustine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prostatic Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vinblastine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vinorelbine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Domenech, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gelabert-Mas, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nogue, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tabernero, J M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Arcusa, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Guasch, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Miguel, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ballesteros, J J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fabregat, X |
773 0# - HOST ITEM ENTRY | |
Title | Acta oncologica (Stockholm, Sweden) |
Related parts | vol. 37 |
-- | no. 2 |
-- | p. 187-91 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1080/028418698429757">https://doi.org/10.1080/028418698429757</a> |
Public note | Available from publisher's website |
No items available.